I am also wondering where the update is. If they are working overtime I take it they have bigger issues than a RNS. Supply demand, workforce other regulatary documents.
Jupiter wanted out from the start and did not want to hold onto the shares as per the article at the time. This is going to rerate next week, I am expecting 5p easy and that is backed in research. 1. Glycotest values at 25m 50% NSCI held 2. ProAxsis revenue making US contracts and a 10min lung test and someone within the company muct be looking at the corona virus and how it can be used. 3. Seed companies worth 1m some looking at Series A funding. 4. Its plain to see PDSB has been a shocker on the NASDAQ but still 8% owned by NSCI and worth 1m to them at present mkt cap. 5. Now Jupiter are out there is still 80% shares held by Major Shareholders in the past the SP has moved rapid on small volumes. This means if the buying persists it will rise very quickly as limited shares available.
79m in issue Nearly 30m traded in a couple of days This is not a pump and dump SP has dropped from 6p in Jan due to Jupiter dumping when they can and have continued into volume.